Globe Life Inc.
NYSE:GLInsurance - Life
+$2.08 today
- Market cap
- $11.70B
- Beta
- 0.50
- P/E (TTM)
- 11.4
- EPS (TTM)
- $15.01
- Dividend yield
- 0.67%
Volume 0.81M
Average 0.53M
GL Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Globe Life Inc.NYSE: GL
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 7.5% from a year ago
Cash & equivalents stood at $257.05M at the end of Q2 FY2026, up 7.5% from a year earlier and up 0.7% from the prior quarter. Over 3 fiscal years it compounded at +16.1% a year.
Context
- Cash & equivalents amounted to 0.8% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +7.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 144.7M USD
- Year-over-year change
- -12.5%
- 4-year CAGR
- +11.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 144.7M | -12.5% |
| FY2024 | 2024-12-31 | 165.33M | +60.3% |
| FY2023 | 2023-12-31 | 103.16M | +11.4% |
| FY2022 | 2022-12-31 | 92.56M | +0.4% |
| FY2021 | 2021-12-31 | 92.16M | — |
Cash & Equivalents vs competitors
How GL compares with its peers on the latest reported figures
- GL's Jun 2026 cash & equivalents of $257.05M is the 10th highest of the 11 companies compared; the peer median is $5.1B.
- Its year-over-year change of +7.5% is the 7th highest of 11, against a peer median of +20.4%.
- Cash & equivalents amounts to 0.8% of total assets for GL, versus a peer median of 2.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $19.3B | -13.0% | +2.9% | 2.5% | |
| Jun 2026 | $15.16B | -8.9% | +4.5% | 1.9% | |
| Jun 2026 | $10.17B | +42.3% | +41.7% | 2.4% | |
| Sep 2026 | $8.53B | +29.1% | +9.4% | 3.6% | |
| Jun 2026 | $5.99B | +58.2% | +9.9% | 1.6% | |
| Sep 2026 | $4.22B | +554.6% | +15.6% | 29.2% | |
| Jun 2026 | $2.1B | +11.6% | +15.7% | 2.0% | |
| Jun 2026 | $1.29B | +68.4% | +140.0% | 3.2% | |
| Jun 2026 | $1.09B | -17.9% | +6.8% | 0.6% | |
| Jun 2026 | $257.05M | +7.5% | +16.1% | 0.8% | |
| Jun 2026 | $199.2M | -83.3% | +9.9% | 0.3% | |
| Peer median (excluding GL) | $5.1B | +20.4% | +9.9% | 2.2% | |
Competitors are the stored peer set for GL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 92.16M | 92.56M | 103.16M | 165.33M | 144.7M |
| Short-term Investments | 21.37B | 16.62B | 17.95B | 17.24B | 17.9B |
| Net Receivables | 738.75M | 848.75M | 900.62M | 961.7M | 1.04B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 22.21B | 17.56B | 18.96B | 18.37B | 19.09B |
| Property, Plant & Equipment (Net) | 205M | 212M | 240M | 285M | 370M |
| Goodwill | 481.79M | 481.79M | 481.79M | 490.45M | 490.45M |
| Intangible Assets | 4.91B | 5.54B | 6.01B | 6.5B | 7B |
| Long-term Investments | 1.38B | 1.59B | 1.77B | 2.33B | 2.57B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 577.63M | 607.63M | 592.41M | 1.11B | 1.3B |
| Total Non-current Assets | 7.56B | 8.43B | 9.1B | 10.71B | 11.72B |
| Total Assets | 29.77B | 25.99B | 28.05B | 29.08B | 30.81B |
| Account Payables | 412.94M | 509.36M | 514.88M | 532.83M | 540.83M |
| Short-term Debt | 479.64M | 449.1M | 486.11M | 415.4M | 304.66M |
| Tax Payables | 1.77B | 434.65M | 494.64M | 731.26M | 0 |
| Deferred Revenue | 65.47M | 253.36M | 254.57M | 257.63M | 270.66M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 2.72B | 1.65B | 1.75B | 1.94B | 1.98B |
| Long-term Debt | 1.55B | 1.63B | 1.63B | 2.32B | 2.32B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 16.86B | 18.76B | 20.18B | 19.51B | 20.54B |
| Total Non-current Liabilities | 18.4B | 20.39B | 21.81B | 21.83B | 22.86B |
| Total Liabilities | 21.13B | 22.04B | 23.56B | 23.77B | 24.84B |
| Common Stock | 109.22M | 105.22M | 102.22M | 97.22M | 92.22M |
| Retained Earnings | 6.18B | 6.89B | 7.48B | 8B | 8.55B |
| Accumulated OCI | 2.68B | (2.79B) | (2.77B) | (2.03B) | (1.77B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 8.64B | 3.95B | 4.49B | 5.31B | 5.97B |
| Total Debt | 2.03B | 2.08B | 2.12B | 2.74B | 2.63B |
| Net Debt | 1.93B | 1.98B | 2.01B | 2.57B | 2.48B |
Globe Life Inc.
NYSE:GL
Intrinsic Alpha fair value
Locked
Current Price
$155.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.